These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9266774)

  • 1. Methamphetamine alters presynaptic glutamate immunoreactivity in the caudate nucleus and motor cortex.
    Burrows KB; Meshul CK
    Synapse; 1997 Oct; 27(2):133-44. PubMed ID: 9266774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity.
    Burrows KB; Meshul CK
    Neuroscience; 1999 Mar; 90(3):833-50. PubMed ID: 10218784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
    Bowyer JF; Gough B; Slikker W; Lipe GW; Newport GD; Holson RR
    Pharmacol Biochem Behav; 1993 Jan; 44(1):87-98. PubMed ID: 8094252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in nerve terminal glutamate immunoreactivity in the nucleus accumbens and ventral tegmental area following single and repeated doses of cocaine.
    Kozell B; Meshul K
    Psychopharmacology (Berl); 2003 Feb; 165(4):337-45. PubMed ID: 12459930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine.
    Pereira FC; Imam SZ; Gough B; Newport GD; Ribeiro CF; Slikker W; Macedo TR; Ali SF
    J Neural Transm (Vienna); 2002 Sep; 109(9):1151-8. PubMed ID: 12203042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.
    Tata DA; Yamamoto BK
    Synapse; 2008 May; 62(5):325-36. PubMed ID: 18288648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion.
    Meshul CK; Allen C
    Synapse; 2000 May; 36(2):129-42. PubMed ID: 10767060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study.
    Gough B; Pereira FC; Fontes Ribeiro CA; Ali SF; Binienda ZK
    Neurochem Int; 2014 Oct; 76():109-13. PubMed ID: 25049173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine.
    Kozell LB; Meshul CK
    Synapse; 2004 Mar; 51(4):224-32. PubMed ID: 14696010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine modulates glutamatergic synaptic transmission in rat primary cultured hippocampal neurons.
    Zhang S; Jin Y; Liu X; Yang L; Ge Zj; Wang H; Li J; Zheng J
    Brain Res; 2014 Sep; 1582():1-11. PubMed ID: 25091639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen.
    Bowyer JF; Clausing P; Gough B; Slikker W; Holson RR
    Brain Res; 1995 Nov; 699(1):62-70. PubMed ID: 8616614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals.
    Northrop NA; Smith LP; Yamamoto BK; Eyerman DJ
    J Pharmacol Exp Ther; 2011 Mar; 336(3):900-7. PubMed ID: 21159748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    Wagstaff JD; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.
    He J; Yang Y; Yu Y; Li X; Li XM
    Behav Brain Res; 2006 Sep; 172(1):39-45. PubMed ID: 16712969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.